{"entity":{"type":"insider","cik":"0001688712","url":"/insider/0001688712","json_url":"/insider/0001688712.json","name":"Bir Dawn Carter","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":7,"first":"2020-11-10","last":"2023-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Bir Dawn Carter","source":"filing","n_filings":7,"first_seen":"2020-11-10","last_seen":"2023-08-17"}],"transactions":[{"id":8608661,"accession":"0001209191-23-046282","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-046282","line_url":"/filing/0001209191-23-046282#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001688712","owner_name":"Bir Dawn Carter","owner_display_name":"Bir Dawn Carter","owner_url":"/insider/0001688712","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":398.0,"shares_display":"398","price_per_share":168.3317,"price_display":"168.33","price_state":"stated","total_value":66996.0166,"total_display":"66,996.02","total_whole":"66,996","shares_owned_after":33805.0,"shares_owned_after_display":"33,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-17","scope":"insider"},{"id":8608656,"accession":"0001209191-23-046282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-046282","line_url":"/filing/0001209191-23-046282#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001688712","owner_name":"Bir Dawn Carter","owner_display_name":"Bir Dawn Carter","owner_url":"/insider/0001688712","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":807.0,"shares_display":"807","price_per_share":169.0367,"price_display":"169.04","price_state":"stated","total_value":136412.6169,"total_display":"136,412.62","total_whole":"136,413","shares_owned_after":34203.0,"shares_owned_after_display":"34,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-17","scope":"insider"},{"id":8334274,"accession":"0001209191-23-043986","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-043986","line_url":"/filing/0001209191-23-043986#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001688712","owner_name":"Bir Dawn Carter","owner_display_name":"Bir Dawn Carter","owner_url":"/insider/0001688712","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":164.5357,"price_display":"164.54","price_state":"stated","total_value":6581428.0,"total_display":"6,581,428.00","total_whole":"6,581,428","shares_owned_after":35010.0,"shares_owned_after_display":"35,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-28","filed_date":"2023-08-01","scope":"insider"},{"id":7835312,"accession":"0001209191-23-030167","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-030167","line_url":"/filing/0001209191-23-030167#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001688712","owner_name":"Bir Dawn Carter","owner_display_name":"Bir Dawn Carter","owner_url":"/insider/0001688712","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":80.955,"price_display":"80.96","price_state":"stated","total_value":33758.235,"total_display":"33,758.24","total_whole":"33,758","shares_owned_after":30885.0,"shares_owned_after_display":"30,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-17","scope":"insider"},{"id":7835309,"accession":"0001209191-23-030167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-030167","line_url":"/filing/0001209191-23-030167#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001688712","owner_name":"Bir Dawn Carter","owner_display_name":"Bir Dawn Carter","owner_url":"/insider/0001688712","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":894.0,"shares_display":"894","price_per_share":85.09,"price_display":"85.09","price_state":"stated","total_value":76070.46,"total_display":"76,070.46","total_whole":"76,070","shares_owned_after":31302.0,"shares_owned_after_display":"31,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-17","scope":"insider"},{"id":8437469,"accession":"0001209191-23-018924","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-018924","line_url":"/filing/0001209191-23-018924#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001688712","owner_name":"Bir Dawn Carter","owner_display_name":"Bir Dawn Carter","owner_url":"/insider/0001688712","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9317.0,"shares_display":"9,317","price_per_share":86.77,"price_display":"86.77","price_state":"stated","total_value":808436.09,"total_display":"808,436.09","total_whole":"808,436","shares_owned_after":32196.0,"shares_owned_after_display":"32,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-13","filed_date":"2023-03-15","scope":"insider"},{"id":7810412,"accession":"0001209191-23-017258","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-23-017258","line_url":"/filing/0001209191-23-017258","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001688712","owner_name":"Bir Dawn Carter","owner_display_name":"Bir Dawn Carter","owner_url":"/insider/0001688712","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42042.0,"shares_display":"42,042","price_per_share":85.20055230483801,"price_display":"85.20","price_state":"stated","total_value":3582001.62,"total_display":"3,582,001.62","total_whole":"3,582,002","shares_owned_after":47506.0,"shares_owned_after_display":"47,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-08","scope":"insider","n_lines":3},{"id":7810401,"accession":"0001209191-23-017258","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-017258","line_url":"/filing/0001209191-23-017258","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001688712","owner_name":"Bir Dawn Carter","owner_display_name":"Bir Dawn Carter","owner_url":"/insider/0001688712","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54954.0,"shares_display":"54,954","price_per_share":89.55889289223714,"price_display":"89.56","price_state":"stated","total_value":4921619.4,"total_display":"4,921,619.40","total_whole":"4,921,619","shares_owned_after":56745.0,"shares_owned_after_display":"56,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider","n_lines":2},{"id":7896918,"accession":"0001209191-23-016278","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016278","line_url":"/filing/0001209191-23-016278#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001688712","owner_name":"Bir Dawn Carter","owner_display_name":"Bir Dawn Carter","owner_url":"/insider/0001688712","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2166.0,"shares_display":"2,166","price_per_share":88.2491,"price_display":"88.25","price_state":"stated","total_value":191147.5506,"total_display":"191,147.55","total_whole":"191,148","shares_owned_after":48509.0,"shares_owned_after_display":"48,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-06","scope":"insider"},{"id":2690540,"accession":"0001209191-20-057705","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-057705","line_url":"/filing/0001209191-20-057705","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001688712","owner_name":"Bir Dawn Carter","owner_display_name":"Bir Dawn Carter","owner_url":"/insider/0001688712","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":162.505,"price_display":"162.50","price_state":"stated","total_value":9750300.0,"total_display":"9,750,300.00","total_whole":"9,750,300","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-10","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001358762","name":"REATA PHARMACEUTICALS INC","url":"/issuer/0001358762","role":"Officer (Chief Commercial Officer)","n_filings":7,"first_seen":"2020-11-10","last_seen":"2023-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001688712","retrieved_at":"2026-08-22T21:56:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}